Acer Therapeutics Inc (NASDAQ:ACER)

2.51
BATS BZX Real-Time Price
As of 2:08pm ET
 -0.06 / -2.33%
Today’s Change
1.08
Today|||52-Week Range
7.25
-37.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$31.3M

Company Description

Acer Therapeutics, Inc. is a pharmaceutical company. The firm engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling on September 19, 2017 and is headquartered in Newton, MA.

Contact Information

Acer Therapeutics, Inc.
One Gateway Center
Newton Massachusetts 02458
P:(844) 902-6100
Investor Relations:
844

Employees

Shareholders

Individual stakeholders40.31%
Mutual fund holders4.04%
Other institutional17.42%

Top Executives

Christopher SchellingPresident, Chief Executive Officer & Director
Harry S. PalminChief Operating & Financial Officer
Jay RobinsonVice President-Information Technology
John KloppChief Technology Officer
Nancy Duarte-LonnrothVice President-Quality